Skip to Main Content

Author Details

Robyn J Barst
Columbia University
1981
226
89
PMIDPaper TitleJournal TitlePublished Year
26583838Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension).Int J Cardiol2016
24566799Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension.Eur Heart J2015
26534956Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.Circulation2015
26210752Long-term safety and efficacy of imatinib in pulmonary arterial hypertension.J Heart Lung Transplant2015
25837032Validation of two predictive models for survival in pulmonary arterial hypertension.Eur Respir J2015
25320967Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study.Chest2015
24176071Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).Am J Cardiol2014
25697042[Pediatric pulmonary hypertension].Turk Kardiyol Dern Ars2014
25697038[New trial designs and potential therapies for pulmonary artery hypertension].Turk Kardiyol Dern Ars2014
25006452Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures? Consensus statement from the Congenital Heart Disease and Pediatric Task Forces, Pulmonary Vascular Research Institute (PVRI).Pulm Circ2014
24988120Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.PLoS One2014
24815795Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension.J Heart Lung Transplant2014
24637559STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.Circulation2014
24628312An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.Am J Respir Crit Care Med2014
22661451Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry.Chest2013
24618537From short-term benefits to long-term outcomes: the evolution of clinical trials in pulmonary arterial hypertension.Pulm Circ2013
24355645New trial designs and potential therapies for pulmonary artery hypertension.J Am Coll Cardiol2013
24355636Pediatric pulmonary hypertension.J Am Coll Cardiol2013
24226806Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association.Circulation2013
23953817One-year experience with intravenous treprostinil for pulmonary arterial hypertension.J Heart Lung Transplant2013
23662203Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee.Pulm Circ2013
23429998Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.Chest2013
23403476Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.Circulation2013
23502781Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension.Nat Genet2013
23563261Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice.Eur Respir J2013
22983573The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe.Haematologica2013
21757572Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management.Chest2012
23009909Congenital heart disease and pulmonary hypertension: pharmacology and feasibility of late surgery.Prog Cardiovasc Dis2012
22883740Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY®.Mayo Clin Proc2012
22818063Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study.J Am Coll Cardiol2012
22837854Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension.Pulm Circ2012
22281797An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.Chest2012
22240409Clinical features of paediatric pulmonary hypertension: a registry study.Lancet2012
22086881Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.Circulation2012
22128226A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.Circulation2012
21778257Portopulmonary hypertension: a report from the US-based REVEAL Registry.Chest2012
20558556The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.Chest2011
22034602Classification of pediatric pulmonary hypertensive vascular disease: Does it need to be different from the adult classification?Pulm Circ2011
21926260PET imaging may provide a novel biomarker and understanding of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension.Circ Cardiovasc Imaging2011
21900080Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.Circulation2011
21527519Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity.Blood2011
21546436Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.Chest2011
21357924Pulmonary arterial hypertension: a comparison between children and adults.Eur Respir J2011
21256048Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension.J Heart Lung Transplant2011
20010555A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension.Clin Pharmacol Ther2010
20688967Pulmonary hypertension and NO in sickle cell.Blood2010
20801850Children deserve the same rights we do: the need for paediatric pulmonary arterial hypertension clinical drug development.Heart2010
20939843How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?Int J Clin Pract Suppl2010
21029834Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings.Am J Cardiol2010
20522584Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective.Chest2010
  • 1 - 50 of 226

Recommended Authors

Intermountain Medical Center
Career Start Year 2016
Number of shared co-authors 0
AHEPA University Hospital, Aristotle University of Thessaloniki
Career Start Year 2016
Number of shared co-authors 1
University of Vermont
Career Start Year 2014
Number of shared co-authors 5
Royal Brompton Hospital
Career Start Year 2010
Number of shared co-authors 2
Boston Children's Hospital, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 5
University of Cambridge, Heart and Lung Research Institute
Career Start Year 2006
Number of shared co-authors 3
Kravis Children's Hospital
Career Start Year 2005
Number of shared co-authors 4
University Hospital Muenster
Career Start Year 2004
Number of shared co-authors 2
Heart Institute, Cincinnati Children's Hospital Medical Center
Career Start Year 2003
Number of shared co-authors 13
University of Pittsburgh
Career Start Year 2002
Number of shared co-authors 3
and Blood Vascular Medicine Institute, University of Pittsburgh School of Medicine
Career Start Year 1999
Number of shared co-authors 6
The Ohio State University Wexner Medical Center
Career Start Year 1997
Number of shared co-authors 11
Hospital for Sick Children
Career Start Year 1997
Number of shared co-authors 10
Cincinnati Children's Hospital Medical Center
Career Start Year 1996
Number of shared co-authors 10
Emory University Division of Cardiology Atlanta Georgia USA.
Career Start Year 1996
Number of shared co-authors 3
Columbia University Medical Center
Career Start Year 1993
Number of shared co-authors 10
National Heart & Lung Institute, Imperial College London.
Career Start Year 1992
Number of shared co-authors 6
Clinical Center/Critical Care Medicine Department, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 2
Baylor College of Medicine and Texas Children's Hospital.
Career Start Year 1991
Number of shared co-authors 5
Wake Forest University School of Medicine
Career Start Year 1989
Number of shared co-authors 1
El Cruce Hospital by Florencio Varela, Lezica Cardiovascular Institute
Career Start Year 1988
Number of shared co-authors 0
The Children's Hospital of Philadelphia
Career Start Year 1988
Number of shared co-authors 12
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1986
Number of shared co-authors 7
Massachusetts General Hospital, Harvard School of Medicine,
Career Start Year 1986
Number of shared co-authors 0
Carver College of Medicine, The University of Iowa
Career Start Year 1984
Number of shared co-authors 7
The Heart Institute, Cincinnati Children's Hospital Medical Center
Career Start Year 1984
Number of shared co-authors 5
Children's Hospital of Philadelphia
Career Start Year 1983
Number of shared co-authors 5
University of Texas Southwestern Medical Center
Career Start Year 1981
Number of shared co-authors 4
the Hospital for Sick Children
Career Start Year 1979
Number of shared co-authors 8
Texas Children's Hospital, Baylor College of Medicine
Career Start Year 1972
Number of shared co-authors 2

Collaborators

Heart Institute, Children's Hospital Colorado, University of Colorado
Co-authored papers 19
Co-authored papers 12
University of Maryland School of Medicine
Co-authored papers 9
Children's Hospital Colorado
Co-authored papers 8
Co-authored papers 6
Boston Children's Hospital, Harvard Medical School
Co-authored papers 4
Duke University Medical Center-Duke Clinical Research Institute
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3
Children's National Hospital, George Washington University School of Medicine
Co-authored papers 3
University of Michigan ann arbor
Co-authored papers 3
Brigham and Women's Hospital
Co-authored papers 3
Co-authored papers 3
Center for Sickle Cell Disease, University of Tennessee Health Science Center
Co-authored papers 2
Stanford University School of Medicine
Co-authored papers 2
Center for Drug Evaluation and Research
Co-authored papers 2
Johns Hopkins University School of Medicine
Co-authored papers 2
Washington University in St. Louis School of Medicine
Co-authored papers 2
University of Wisconsin School of Medicine and Public Health
Co-authored papers 2
Co-authored papers 2
John Hopkins School of Medicine
Co-authored papers 2
West Virginia University
Co-authored papers 2
Center for Sickle Cell Disease, Howard University College of Medicine
Co-authored papers 2
Harvard Medical School
Co-authored papers 2
University of Iowa
Co-authored papers 2
university of california san diego
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Mayo Clinic Rochester MN USA.
Co-authored papers 1